Show
Sort by
-
- Journal Article
- A1
- open access
Dupilumab efficacy in patients with uncontrolled or oral corticosteroid-dependent allergic and nonallergic asthma
-
- Journal Article
- A1
- open access
Safety and effectiveness of as-needed formoterol in asthma patients taking inhaled corticosteroid (ICS)-formoterol or ICS-salmeterol maintenance therapy
-
- Journal Article
- A1
- open access
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma : UK database study
-
- Journal Article
- A1
- open access
The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy
-
- Journal Article
- A1
- open access
The indispensable nasal decongestant : patients' views and perspectives on nasal decongestant overuse
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures
-
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases